resource-symbol

Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

Calin Andrei

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Developed in 1994

See also the BASFI and BASMI

Authors

Calin Andrei

Copyright
BASDAI © Andrei Calin, 1994
Objective
To define disease activity in patients with ankylosing spondylitis
Therapeutic area
  • Musculoskeletal Diseases
Therapeutic indication

Spondylitis, Ankylosing

Type of Clinical Outcome Assessment (COA)
  • PRO PRO
Original language(s)
  • English for the UK
Bibliographic reference(s) of the original questionnaire

Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994 Dec;21(12):2286-91 (PubMed Abstract)


Contact and conditions of use

Authors

Calin Andrei

Dr Andrei Calin, MD, FRCP
Consultant Rheumatologist
Phone: + 44 (0) 1225 421 760
E-mail: andrei.calin@cantab.net

Andrei Calin Publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study 1 300 € (For use in commercial epidemiologic / observational / marketing studies: please consult the User Agreement)
Cost per language 700 €
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 550 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Conditions to translate

Please refer to the "Languages" tab

Conditions to implement in electronic applications

Exclusive licensor for e-versions of the questionnaireMapi Research Trust

Academic and Commercial Users
  • Shall follow the “Conditions of use”  mentioned above
  • In addition, in case the electronic version of the questionnaire is developed by a third party (IT Company, e-PRO vendor…), User shall check with Mapi Research Trust that this third party has signed the necessary License Agreement with Mapi Research Trust before developing the electronic version of the Questionnaire.

Information Technology (IT) Companies (incl. ePRO vendors)
  • In case of a one-shot development and commercial use of an electronic version of the questionnaire by the IT Company, the IT Company shall:
    • Sign a “Specific-Study License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the questionnaire for the specific study only
      • shall not permit the IT Company to promote the electronic version of the questionnaire or its use for another study or another client
    • Pay a one-shot license fee per study to Mapi Research Trust: 500 Euros
  • In case of an IT Company who wishes to develop an electronic version of the questionnaire and would like to obtain a non-exclusive license to market and promote their devices / tablets / smartphones / e-applications using the questionnaire, the IT Company shall:
    • Sign a “General License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the questionnaire on multiple devices for multiple studies and clients
      • permitting the IT Company to promote the electronic versions of the questionnaire by any marketing means (including, but not limited to, IT Company’s  promotional documents / websites / press release / communication during conferences / webinars)
    • Pay an annual administrative fee of 2,500 Euros to Mapi Research Trust
    • Pay an annual royalty fee of 2,500 Euros to the authors

Author Website(s)

Additional information on the BASDAI website

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Online distribution

For Non-Funded Academic Studies

The following licensing process is restricted to academic users:

  • Who do not receive specific funding for their study
  • Who intend to use the questionnaire in individual clinical practice or research study

Should you not correspond to this category of users, please send us a request.

Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.

If you are interested in specific language(s), please first consult the list of existing translations in PROQOLID.

Login

To access this section, please complete a client account.

Languages

Original language(s)

  • English for the UK

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

BASDAI

Afrikaans for South Africa*
Arabic for Algeria*
Arabic for Egypt*
Arabic for Israel*
Arabic for Kuwait*
Arabic for Qatar*
Arabic for Saudi Arabia*
Arabic for the United Arab Emirates*
Azerbaijani for Azerbaijan*
Bengali for India*
Bulgarian for Bulgaria*
Cantonese for Hong Kong*
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for Hong Kong*
English for India*
English for New Zealand*
English for South Africa*
English for the USA*
Estonian for Estonia*
Finnish for Finland*
French for Algeria*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Gujarati for India*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Italian for Switzerland*
Japanese for Japan*
Kannada for India*
Korean for Korea*
Latvian for Latvia*
Lithuanian for Lithuania*
Malay for Malaysia*
Malayalam for India*
Mandarin for China*
Mandarin for Taiwan*
Marathi for India*
Norwegian for Norway*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Punjabi for India*
Romanian for Romania
Russian for Belarus*
Russian for Estonia*
Russian for Israel*
Russian for Latvia*
Russian for Lithuania*
Russian for Russia*
Russian for Ukraine*
Serbian for Serbia*
Sesotho for South Africa*
Slovak for Slovakia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Mexico
Spanish for Spain*
Spanish for the USA*
Swahili for Kenya*
Swedish for Finland*
Swedish for Sweden*
Tamil for India*
Telugu for India*
Turkish for Turkey*
Ukrainian for Ukraine*
Urdu for India*
Xhosa for South Africa*
Zulu for South Africa*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

More information on translations

Bibliographic reference of the French translation:

Claudepierre P, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F, Clerc D, Berthelot JM, Vergne P, Roudot-Thoraval F, Larget-Piet B, Chevalier X.  Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol. 1997 Oct;24(10):1954-8

Bibliographic reference of the Dutch translation:

Van Tubergen A, Debats I, Ryser L, Londoño J, Burgos Vargas R, Cardiel M H, Landewé R, Stucki G, Van der Heijde D, V. Use of a numerical rating scale as an answer modality in ankylosing spondylitis specific questionnaires. Arthritis Care and Research, 2002;47(3): 242−248

Tubergen A V, Coenen J, Landewé R, Spoorenberg A, Chorus A, Boonen A, Linden S, Heijde D. Assessment of fatigue in patients with ankylosing spondylitis: A psychometric analysis. Arthritis Care and Research, 2002;47(1):8−16

Bibliographic reference of the German translation:

Bönisch A, Ehlebracht König I. (The BASDAI−D−−an instrument to defining disease status in  ankylosing spondylitis and related diseases). Zeitschrift für Rheumatologie 2003;62 (3): 251−63

Bibliographic reference of the Italian translation:

Biasi D, Carletto A, Caramaschi P, Bambara L M. An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores.The Journal of rheumatology,1996; 23 (2),407−8

Cauli A, Dessole G, Fiorillo M T, Vacca A, Mameli A, Bitti P, Passiu G, Sorrentino R, MathieuA. Increased level of HLA−B27 expression in ankylosing spondylitis patients compared with healthy HLA−B27−positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology; 2002; 41(12): 1375−9

Bibliographic reference of the Spanish for Mexico translation:

Cardiel−M−H, Londoño−J−D, Gutiérrez−E, Pacheco−Tena−C, Vázquez−Mellado−J, Burgos−Vargas−R. Translation, cross−cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. 2003 Jul−Aug, VOL: 21 (4), P: 451−8

Bibliographic reference of the Spanish translation:

Ariza−Ariza−Rafael, Hernández−Cruz−Blanca, Navarro−Sarabia−Federico. Physical function and health−related quality of life of Spanish patients with ankylosing spondylitis. Arthritis and rheumatism; 2003;49(4) 483−7

Bibliographic reference of the Swedish translation:

Waldner−A, Cronstedt−H, Stenström−C−H. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity. Scandinavian journal of rheumatology. Supplement  1999;111:10−6

E-versions

Tablet

  • Implemented electronically by Kayentis

Conditions to implement in electronic applications

Please refer to the "Contact and conditions of use" tab

Last update: May 2017
For additional information, please submit a request. More information in our FAQs.

YOU MIGHT ALSO BE INTERESTED IN:

PROLABELS symbol PROLABELS: 24 indications
PROINSIGHT symbol PROINSIGHT: 1 guidance